Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy selections remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/blackrock-expands-buidl-fund-to-solana-signaling-major-institutional-adoption/